Condition: Stroke Patients · Stroke · Stroke; Sequelae · Sponsor: The Florey Institute of Neuroscience and Mental Health
The Investigators are running a small, early-phase research study across several hospitals in Melbourne, Australia. The study will involve up to 100 young adults between the ages of 18 and 55 who have had a stroke. The goal is to test how practical it is to carry out a detailed health assessment process-called "deep phenotyping"-with this group. This process involves collecting a wide range of information and samples from stroke survivors to better understand each participant's condition. The Investigators will look at how well this approach works in practice, including how easy it is to use, whether it's done consistently, and how acceptable it is to participants. At the same time, the Investigators will also explore how different factors-such as biological markers (biomarkers), age, sex, type of stroke, lifestyle, and environment-might be related to stroke recovery. This pilot study will prepare for larger studies in the future.
This description comes directly from the study's public registry record.
Emily Ramage, BPhysio, PhD · +61 3 90357000 · emily.ramage@florey.edu.au
Marie Ferraro, BSc · +61390357000 · marie.ferraro@student.unimelb.edu.au
Always discuss trial participation with your own doctor first.
| Austin Health | Heidelberg, Victoria, Australia | Recruiting |
| Florey Institute of Neuroscience and Mental Health, Melbourne Brain Centre | Heidelberg, Victoria, Australia | Not Yet Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07019493